Clinical Trial Update: Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fingolimod to interferon beta-1b in adults with multiple sclerosis to assess cognitive symptoms; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fingolimod (fingolimod)
• Interferon beta-1b (Interferon beta-1b)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2017-03-21